Description

Ondero Met 2. 5/500 Tablet is a medicine that contains Linagliptin as its active ingredient. It is used in the treatment of type 2 diabetes mellitus. Linagliptin belongs to a class of drugs called dipeptidyl peptidase-4 inhibitors, which work by increasing the levels of incretin hormones in the body. These hormones help to lower blood sugar levels by stimulating the release of insulin and reducing the amount of glucose produced by the liver. Ondero Met 2. It is important to follow the prescribed dosage and duration of treatment to effectively manage diabetes. Common side effects of Ondero Met 2. 5/500 Tablet may include hypoglycemia (low blood sugar), headache, stomach upset, and respiratory tract infections. It is important to inform a healthcare provider about any existing medical conditions or medications taken before starting this treatment.

Additional information